Primperan 10 mg/2 ml solution for injection

Spain
Brand name Primperan 10 mg/2 ml solution for injection
Form solution for injection
Active substance / Dosage
Prescription type Prescription Only Medicine
Registration number 40256
Primperan 10 mg/2 ml solution for injection solution for injection

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Primperan 10 mg/2 ml injection solution

Metoclopramide hydrochloride

Read the entire leaflet carefully before you start using this medicine, as it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
  • If you experience any adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet. See section 4.

Leaflet contents:

  1. What Primperan is and what it is used for

  2. What you need to know before using Primperan

  3. How to use Primperan

  4. Possible side effects

  5. How to store Primperan

  6. Contents of the pack and other information

1. What Primperan is and what it is used for

Primperan is an antiemetic. It contains a medicine called “metoclopramide”. It acts on an area of the brain that prevents nausea or vomiting.

Adult population

Primperan is used in adults:

  • to prevent nausea and vomiting that may occur after surgery
  • to treat nausea and vomiting, including nausea and vomiting associated with migraine
  • to prevent nausea and vomiting caused by radiotherapy.

Pediatric population

Primperan is used in children (1–18 years of age) only if other treatments do not work or cannot be used:

  • to prevent delayed nausea and vomiting that may occur after chemotherapy
  • to treat nausea and vomiting that may occur after surgery.

2. What you need to know before using Primperan

Do not use Primperan

  • if you are allergic to metoclopramide or any of the other ingredients of this medicine (listed in section 6)
  • if you have bleeding, obstruction, or perforation in the stomach or intestine
  • if you have or may have a rare tumor of the adrenal gland near the kidney (pheochromocytoma)
  • if you have ever experienced involuntary muscle spasms (tardive dyskinesia) while being treated with a medicine
  • if you have epilepsy
  • if you have Parkinson's disease
  • if you are taking levodopa (a medicine for Parkinson's disease) or dopaminergic agonists (see below "Use of Primperan with other medicines")
  • if you have ever had abnormal levels of blood pigments (methemoglobinemia) or deficiency of NADH-cytochrome b5 reductase.

Do not administer Primperan to children under 1 year of age (see below "Children and adolescents").

Do not use Primperan if any of the above apply to you. If you are unsure, consult your doctor, pharmacist, or nurse before using Primperan.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before using Primperan if:

  • you have a history of abnormal heartbeats (QT interval prolongation) or any other heart problems
  • you have problems with electrolyte levels in your blood, such as potassium, sodium, or magnesium
  • you are taking other medicines known to affect your heart rhythm
  • you have any neurological (brain) disorders
  • you have liver or kidney problems. Your dose may need to be reduced (see section 3).

Your doctor may perform blood tests to monitor your blood pigment levels. If abnormal levels (methemoglobinemia) occur, treatment must be stopped immediately and permanently.

Do not exceed 3 months of treatment due to the risk of involuntary muscle spasms.

Children and adolescents

Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults. This medicine should not be used in children under 1 year of age due to the high risk of uncontrollable movements (see above "Do not use Primperan").

Use of Primperan with other medicines

Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might need to take any other medicines. This is because some medicines may affect how Primperan works, or Primperan may affect how other medicines work. These medicines include:

  • levodopa or other medicines used to treat Parkinson's disease (see above "Do not use Primperan")
  • anticholinergics (medicines used to relieve stomach spasms or cramps)
  • morphine derivatives (medicines used to treat severe pain)
  • sedative medicines
  • any medicine used to treat mental health conditions
  • digoxin (a medicine used to treat heart failure)
  • cyclosporine (a medicine used to treat certain immune system disorders)
  • mivacurium and suxamethonium (medicines used to relax muscles)
  • fluoxetine and paroxetine (medicines used to treat depression)
  • rifampicin (a medicine used to treat tuberculosis or other infections), which may reduce the amount of metoclopramide in the blood if taken at the same time.

Use of Primperan with alcohol

Alcohol should not be consumed during treatment with metoclopramide, as it increases the sedative effect of Primperan.

Pregnancy and breastfeeding

If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine.

Primperan may be used during pregnancy if necessary. Your doctor will decide whether this medicine should be administered.

Primperan is not recommended during breastfeeding because metoclopramide passes into breast milk and may affect your baby.

Driving and using machines

After using Primperan, you may feel drowsy, dizzy, or experience uncontrollable movements such as tics, jerks, or twisting and unusual muscle tone that may distort your body. These effects may impair your vision and may interfere with your ability to drive or operate machinery.

Primperan 10 mg/2 ml solution for injection contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per 1 ml of injectable solution; hence, it is essentially "sodium-free".

3. How to use Primperan

Follow exactly the instructions for administration of this medicine as given by your doctor. If in doubt, consult your doctor, pharmacist, or nurse again.

This medicine will normally be administered by a doctor or nurse. It will be given as a slow injection into a vein (over at least 3 minutes) or as an injection into a muscle.

In adult patients

For the treatment of nausea and vomiting, including nausea and vomiting associated with migraine, and for the prevention of nausea and vomiting caused by radiotherapy: a single dose of 10 mg is recommended, which may be repeated up to 3 times daily.

The maximum recommended daily dose is 30 mg or 0.5 mg/kg body weight.

For the prevention of nausea and vomiting that may occur after surgery: a single dose of 10 mg is recommended.

All indications (pediatric patients aged 1–18 years)

The recommended dose is 0.1 to 0.15 mg/kg body weight, which may be repeated up to three times daily, administered slowly into a vein.

The maximum dose in 24 hours is 0.5 mg/kg body weight.

Dosing table

Age

Body weight

Dosage

Frequency

1-3 years

10-14 kg

1 mg

Up to 3 times daily

3-5 years

15-19 kg

2 mg

Up to 3 times daily

5-9 years

20-29 kg

2.5 mg

Up to 3 times daily

9-18 years

30-60 kg

5 mg

Up to 3 times daily

15-18 years

Over 60 kg

10 mg

Up to 3 times daily

The treatment should not exceed 48 hours for the treatment of nausea and vomiting occurring after surgery.

The treatment should not exceed 5 days for the prevention of nausea and vomiting that may occur after chemotherapy.

Special populations

Elderly population

Dosage reduction may be necessary depending on kidney problems, liver problems, and general health status.

Adults with renal impairment

Inform your doctor if you have kidney problems. The dose should be reduced if you have moderate to severe renal impairment.

Adults with hepatic impairment

Inform your doctor if you have liver problems. The dose should be reduced if you have severe hepatic impairment.

Children and adolescents

Metoclopramide must not be used in children under 1 year of age (see section 2).

If you use more Primperan than you should

Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), drowsiness, altered consciousness, confusion, hallucinations, and heart problems. Your doctor may prescribe treatment for these effects if necessary.

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at telephone number: 91 562 04 20, stating the medication and the amount ingested.

If you forget to use Primperan

Do not use a double dose to make up for missed doses.

If you have any further questions about the use of this medicine, ask your doctor, nurse, or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Frequency not known (frequency cannot be estimated from the available data)

  • Allergic reactions (such as anaphylaxis, angioedema, and urticaria).

Symptoms may include rash, itching, difficulty breathing, shortness of breath, swelling of the face, lips, throat, or tongue, cold, clammy skin, palpitations, dizziness, weakness, or fainting.

Contact your doctor or other healthcare professional immediately or go to the nearest hospital emergency department straight away.

Stop treatment and inform your doctor, pharmacist, or nurse immediately if you experience any of the following signs while taking this medicine:

  • Uncontrollable movements (often affecting the head and neck). These may occur in children and young adults, particularly when high doses are used. These symptoms usually appear early in treatment and may even occur after a single dose. These movements will cease when appropriately treated.
  • High fever, high blood pressure, seizures, sweating, excessive salivation. These may be signs of a condition called neuroleptic malignant syndrome.
  • Itching and skin rashes, swelling of the face, lips, or throat, difficulty breathing. These may be signs of an allergic reaction, which may be severe.

Very common (may affect more than 1 in 10 people)

  • Feeling sleepy.

Common (may affect up to 1 in 10 people)

  • Depression
  • Uncontrollable movements such as tics, jerks, twisting movements, or muscle contractures (stiffness, rigidity)
  • Parkinsonism-like symptoms (stiffness, tremor)
  • Feeling restless
  • Decreased blood pressure (particularly with intravenous administration)
  • Diarrhea
  • Feeling weak.

Uncommon (may affect up to 1 in 100 people)

  • Elevated blood levels of a hormone called prolactin, which may cause: milk production in men and women who are not breastfeeding
  • Irregular periods
  • Hallucinations
  • Decreased level of consciousness
  • Slow heart rate (particularly with intravenous administration)
  • Allergic reaction
  • Visual disturbances and involuntary deviation of the eyeball.

Rare (may affect up to 1 in 1,000 people)

  • Confusion
  • Seizures (especially in patients with epilepsy).

Frequency not known (frequency cannot be estimated from the available data)

  • Abnormal levels of blood pigments: which may change the color of your skin
  • Abnormal breast development (gynecomastia)
  • Involuntary muscle spasms after prolonged use, particularly in elderly patients
  • High fever, high blood pressure, seizures, sweating, excessive salivation. These may be signs of a condition called neuroleptic malignant syndrome
  • Changes in heart rhythm, which may be seen on an ECG (electrocardiogram)
  • Cardiac arrest (particularly with intravenous administration)
  • Shock (severe drop in blood pressure) (particularly with intravenous administration)
  • Fainting (particularly with intravenous administration)
  • Very high blood pressure
  • Suicidal thoughts.

Reporting of adverse effects

If you experience any adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect not listed in this leaflet. You can also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Primperan

Keep this medicine out of the sight and reach of children.

No specific temperature requirements are necessary; store in the original container to protect from light.

Do not use Primperan after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.

6. Contents of the pack and other information

Composition of Primperan 10 mg/2 ml injectable solution

  • The active substance is metoclopramide hydrochloride. Each 2 ml ampoule contains 10 mg of metoclopramide hydrochloride.

  • The other components are: sodium chloride and water for injections.

Appearance of the product and contents of the pack

It is an injectable solution packed in 2 ml ampoules for administration by intramuscular or intravenous route.

Each pack contains 12 ampoules of 2 ml.

Other presentations:

Primperan 10 mg tablets: Packs containing 30 and 60 tablets

Primperan 1 mg/ml oral solution: 200 ml bottle

Marketing Authorization Holder

sanofi-aventis, S.A.

C/ Rosselló i Porcel, 21

08016 Barcelona

Spain

Manufacturer

Delpharm Dijon

6, Boulevard de l’Europe

21800 Quetigny

France

Date of the most recent review of this leaflet: February 2023

Detailed information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/